Prescription written in sloppy handwriting? This start-up offers an antidote
Equipping doctors with digital tools, Farmako aims to build India’s first centralised health record system
Shailaja Mohapatra - January 14, 2021
When the sun shines
Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia
Shailaja Mohapatra - January 16, 2021
Selling prescription drugs can be a pain. Doceree offers an easy way out
The pharma-marketing start-up has patented tech to reach the right message to the right doctor
Debangana Ghosh - November 04, 2020
Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?
Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh
V Keshavdev - December 10, 2020
“I do not take the market’s view as gospel truth, but I also do not assume it is foolish or stupid”
ASK Group’s Bharat Shah on why the market is his guidepost when it comes to deciphering tangible price and intangible value
N Mahalakshmi - October 17, 2020
Chronic profit
Eris Lifesciences promoter Himanshu Shah sells stock worth ₹968 million
Shailaja Mohapatra - October 08, 2020
Take a chill pill
Work from home can be stressful. Let PharmEasy make one chore easier for you
Shailaja Mohapatra - October 06, 2020
Why Aarti Industries’ low-cost manufacturing and relationship with MNCs will power its growth
Customers have begun to prefer long-term contracts because they want supply security, reveals managing director Rajendra Gogri
Krishna Gopalan - September 30, 2020
Welcome to the Mad Hatters Party a.k.a investors going overboard on 'quality' companies
The market has been behaving erratically but amid the insanity here are some sane observations
N Mahalakshmi - September 30, 2020
Building a future-ready, innovative healthcare industry
India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic care
Kiran Mazumdar-Shaw - August 28, 2020
